Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TAK-418 is a selective and orally active inhibitor of LSD1/KDM1A enzyme with an IC50 of 2.9 nM. TAK-418 unlocks abnormal epigenetic mechanisms and improves autism symptoms in models of neurodevelopmental disorders.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 233.00 | |
5 mg | In stock | $ 578.00 | |
10 mg | In stock | $ 913.00 | |
25 mg | In stock | $ 1,870.00 | |
50 mg | In stock | $ 2,520.00 | |
100 mg | In stock | $ 3,380.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 678.00 |
Description | TAK-418 is a selective and orally active inhibitor of LSD1/KDM1A enzyme with an IC50 of 2.9 nM. TAK-418 unlocks abnormal epigenetic mechanisms and improves autism symptoms in models of neurodevelopmental disorders. |
Targets&IC50 | LSD1/KDM1A:2.9 nM |
In vivo |
TAK-418 (1 mg/kg; oral; once daily for 14 days) improves certain autism spectrum disorder (ASD)-like behaviors in rodents that model neurodevelopmental disorders.[1] TAK-418 increases H3K4me1/2/3 and H3K9me2 levels of the Ucp2 gene and induces Ucp2 mRNA expression in primary cultured rat neurons. TAK-418 also increases H3K4me1/2/3 of the Bdnf gene. TAK-418 avoids steric interference of GFI1B in the binding pocket by generating a tightly formylated adduct form of coenzyme flavin adenine dinucleotide (FAD). TAK-418 exhibits favorable pharmacokinetic profiles in rodents and inhibits LSD1 enzymatic activity in the brain without causing hematological toxicity in rodents.[1] A single administration of 1 or 3 mg/kg of TAK-418 increases H3K4me2 levels of the Ucp2 gene in the mouse brain.[1] TAK-418 can improve neurological problems at cellular, molecular, gene expression, functional, and functional levels in the KS mouse model (Kmt2d+/βGeo mice).[2] |
Molecular Weight | 356.91 |
Formula | C17H25ClN2O2S |
CAS No. | 1818252-53-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 49.5 mg/mL (138.7 mM), Sonication and heating to 60℃ are recommended.
H2O: 15.0 mg/mL (42.0 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TAK-418 1818252-53-7 Chromatin/Epigenetic Histone Demethylase TAK 418 TAK418 inhibitor inhibit